Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma
Background: Although with the introduction of novel agents, clinical outcomes have significantly improved in patients of multiple myeloma (MM); however, nearly all relapse, requiring subsequent treatment. Patients who have been heavily treated for relapsed/refractory MM (RRMM) have limited options a...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-01-01
|
| মালা: | Indian Journal of Medical and Paediatric Oncology |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=6;spage=846;epage=849;aulast=Dubey |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|